Radiology Partners' Cognita Chest X-ray AI tool earns FDA Breakthrough Device status for multiple clinical uses.
Key Details
- 1Radiology Partners' Cognita business received FDA Breakthrough Device designation for its Chest X-ray AI tool.
- 2The tool uses a generative vision-language model to assist radiologists in X-ray interpretation.
- 3This is among the first vision-language AI solutions in radiology to receive this designation.
- 4Breakthrough status expedites regulatory review for devices addressing critical needs.
- 5Cognita CXR integrates into radiology workflows to generate comprehensive preliminary reports for physician review.
Why It Matters
FDA Breakthrough Device designation is a major step for AI-driven radiology tools, signaling both clinical promise and regulatory progress. This can accelerate the path toward broader clinical deployment of advanced AI models in everyday radiology practice.
Source
Radiology Business
Related News
•Radiology Business
NYC Health + Hospitals CEO Considers AI to Replace Radiologists
NYC Health + Hospitals CEO suggests AI could partially replace radiologists, pending regulatory approval.
•Radiology Business
Deepfake X-rays Fool Radiologists and AI, Raising Security Concerns
Both radiologists and AI models struggle to differentiate between authentic and AI-generated ('deepfake') radiographic images, raising major security and clinical concerns.
•AuntMinnie
AI-Supported Mammography Screening Boosts Cancer Detection, Lowers Workload
Partially autonomous AI screening for mammography safely increases cancer detection while reducing radiologist workload.